title: To the Editor.
authors.forename: Moshe
authors.initials: M
authors.lastname: Solomonow
mesh_terms: D000818:Animals; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage / Q000494:pharmacology; D000911:Antibodies, Monoclonal / Q000276:immunology / Q000494:pharmacology*; D004318:Doxycycline / Q000494:pharmacology*; D000069285:Infliximab; D007403:Intervertebral Disc / Q000187:drug effects* / Q000503:physiopathology; D017116:Low Back Pain / Q000503:physiopathology / Q000517:prevention & control*; D010147:Pain Measurement / Q000379:methods; D051381:Rats; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors* / Q000276:immunology / Q000378:metabolism
chemical_list: D000893:Anti-Inflammatory Agents; D000911:Antibodies, Monoclonal; D014409:Tumor Necrosis Factor-alpha; D000069285:Infliximab; D004318:Doxycycline